Doxorubicin-associated hyperpigmentation.
Curran
C F
CF
D004317:Doxorubicin / Q000009:adverse effects*; D006801:Humans; D010859:Pigmentation Disorders / Q000139:chemically induced* / Q000523:psychology; D011358:Product Surveillance, Postmarketing
D004317:Doxorubicin